Planmeca’s recent investment in E4D Technologies promises to expand the brand globally

January 8, 2014
Issue 1

Planmeca’s non-controlling, strategic investment in E4D Technologies is said to reinforce the company’s commitment to improving patient care by offering a comprehensive portfolio of integrated digital dental solutions for dentists and dental laboratories.

Planmeca’s non-controlling, strategic investment in E4D Technologies is said to reinforce the company’s commitment to improving patient care by offering a comprehensive portfolio of integrated digital dental solutions for dentists and dental laboratories.

Planmeca will co-develop CAD/CAM products for the North American market in partnership with E4D Technologies under the brand names Planmeca PlanScan-E4D Technologies and PlanMill-E4D Technologies. Henry Schein will reportedly continue to be the exclusive distributor of these products in the United States, Canada, Australia, and New Zealand.  Also, Planmeca plans to expand distribution of the E4D system to an additional 120 international markets under the PlanScan and PlanMill brands.  The E4D brand name will remain in use in certain additional markets.

“Planmeca’s investment in E4D Technologies offers us an opportunity to grow our company globally,” said Dr. Gary Severance, Chief Marketing Officer for E4D Technologies. “In addition, Planmeca has been a market leader in extra-oral digital imaging for many years, and we look forward to furthering the seamless integration of our CAD/CAM platform with the additional digital solutions offered by Planmeca. Our customers will benefit from the combination of these unique and innovative products and services.”

Under the new agreement, Planmeca joins an existing partnership between E4D Technologies, Henry Schein and Ivoclar Vivadent, who have been strategic equity partners with the developer of the E4D CAD/CAM Restorative System since 2007.

For more information about E4D Technologies’ products, head to the company’s listing on Dental Products & Reviews here.